JCJuliana Xavier de Miranda Cerqueira

Juliana Xavier de Miranda Cerqueira

*This is an algorithmically generated author record based on publicly available information.

Juliana Xavier de Miranda Cerqueira has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Advancing intercontinental collaboration in human genetics: success story of the African and European Young Investigator Forum

    by Mohamed Zahir Alimohamed, Khuthala Mnika, Samuel Mawuli Adadey, Rita Barbosa-Matos, Elena Avram, Patracia Nevondwe, Wisdom A. Akurugu, Wilson Mupfururirwa, Juliana Xavier de Miranda Cerqueira, Rhys Dore, et al.

  • Open Access

    The European Society of Human Genetics—Young committee- activities and achievements between 2019–2022

    by Elena Avram, Can Ding, Juliana Xavier de Miranda Cerqueira, Mridul Johari, Ana Raquel Gouveia Freitas da Silva, Ileana-Delia Săbău, Nuru Noor, Silvia Kalantari, Rhys Dore, Rita Barbosa-Matos, et al.

    The European Society of Human Genetics—Young Committee (ESHG-Y) aims to support young human geneticists by developing strategies and programs for better education and creating a strong network in all European countries. In this report, we present the ESHG-Y projects conducted since its conception. We organized the educational sessions at the ESHG Annual Conference, the European Dysmorphology Meetings, and a virtual session in collaboration with the European Board of Medical Genetics (EBMG). Also, the ESHG-Y regularly promotes relevant activities and succeeded in creating an active network of young geneticists. Our representatives have a supportive role in well-known organizations such as: ESHG Board, ESHG Scientific Program Committee, ESHG Education Committee, EBMG, ERN-Ithaca, Unique - Rare Chromosome Disorder Support group, Orphanet, EuroGEMS, MOOC BIG and more. Taking into consideration all activities and ongoing projects, we can state that the ESHG-Y successfully achieves its objectives and brings young professionals together.


  • Open Access

    Independent and cumulative coeliac disease-susceptibility loci are associated with distinct disease phenotypes

    by Juliana X. M. Cerqueira, Päivi Saavalainen, Kalle Kurppa, Pilvi Laurikka, Heini Huhtala, Matti Nykter, Lotta L. E. Koskinen, Dawit A. Yohannes, Elina Kilpeläinen, Anastasia Shcherban, et al.

    The phenotype of coeliac disease varies considerably for incompletely understood reasons. We investigated whether established coeliac disease susceptibility variants (SNPs) are individually or cumulatively associated with distinct phenotypes. We also tested whether a polygenic risk score (PRS) based on genome-wide associated (GWA) data could explain the phenotypic variation. The phenotypic association of 39 non-HLA coeliac disease SNPs was tested in 625 thoroughly phenotyped coeliac disease patients and 1817 controls. To assess their cumulative effects a weighted genetic risk score (wGRS39) was built, and stratified by tertiles. In our PRS model in cases, we took the summary statistics from the largest GWA study in coeliac disease and tested their association at eight P value thresholds (PT) with phenotypes. Altogether ten SNPs were associated with distinct phenotypes after correction for multiple testing (PEMP2 ≤ 0.05). The TLR7/TLR8 locus was associated with disease onset before and the SH2B3/ATXN2, ITGA4/UBE2E3 and IL2/IL21 loci after 7 years of age. The latter three loci were associated with a more severe small bowel mucosal damage and SH2B3/ATXN2 with type 1 diabetes. Patients at the highest wGRS39 tertiles had OR > 1.62 for having coeliac disease-related symptoms during childhood, a more severe small bowel mucosal damage, malabsorption and anaemia. PRS was associated only with dermatitis herpetiformis (PT = 0.2, PEMP2 = 0.02). Independent coeliac disease-susceptibility loci are associated with distinct phenotypes, suggesting that genetic factors play a role in determining the disease presentation. Moreover, the increased number of coeliac disease susceptibility SNPs might predispose to a more severe disease course.


  • Effects of selenium compounds on proliferation and epigenetic marks of breast cancer cells

    by Juliana Xavier de Miranda, Fábia de Oliveira Andrade, Aline de Conti, Maria Lúcia Zaidan Dagli, Fernando Salvador Moreno, Thomas Prates Ong


  • Proinflammatory and oxidative stress markers in patients submitted to Roux-en-Y gastric bypass after 1 year of follow-up

    by V R G da Silva, E A M Moreira, D Wilhelm-Filho, J X de Miranda, J P Benincá, S V G Vigil, A M B Moratelli, T R Garlet, M S de Souza Meirelles, H Vannucchi, et al.

    This study examined the effect of weight loss after 3, 6 and 12 months of Roux-en-Y Gastric Bypass (RYGB) on energy intake and on several biomarkers of oxidative stress such as levels of vitamin C, beta-carotene, vitamin E (diet/blood), nitric oxide metabolites (NOx), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), reduced glutathione (GSH) and activity of catalase (CAT). Study with a control group (CG), assessed once, and a bariatric group (BG) assessed at the basal period as well as at 3, 6 and 12 months post-surgery; both groups were composed of 5 men and 31 women (n=36). Age was 38.7±9.4 and 39.6±9.2 years old and body mass index (BMI) was 22.2±2.1 and 47.6±9.1 kg/m2, respectively. The variance measure quoted was SEM. The body weight at 12 months was 35.8±1.0% (PP=0.007) and TBARS (PPPP=0.037), whereas CAT activity was increased (P=0.029). After 12 months levels of NOx (P=0.004), TBARS (PPPP<0.001) were increased compared with controls. RYGB followed by a daily vitamin supplement apparently attenuated pro-inflammatory and oxidative stress markers 1 year after surgery, but additional antioxidant supplementation appears necessary.